CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 136 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $8,260,835 | +448.6% | 349,739 | +246.3% | 0.00% | +200.0% |
| Q3 2023 | $1,505,910 | +36.2% | 101,000 | 0.0% | 0.00% | – |
| Q2 2023 | $1,105,950 | +233.1% | 101,000 | -5.3% | 0.00% | – |
| Q1 2022 | $332,000 | -7.5% | 106,600 | +0.4% | 0.00% | – |
| Q4 2021 | $359,000 | -7.5% | 106,200 | 0.0% | 0.00% | – |
| Q3 2021 | $388,000 | -16.2% | 106,200 | 0.0% | 0.00% | – |
| Q2 2021 | $463,000 | +4.5% | 106,200 | +8.8% | 0.00% | – |
| Q1 2021 | $443,000 | -20.9% | 97,600 | 0.0% | 0.00% | – |
| Q4 2020 | $560,000 | -27.5% | 97,600 | -8.4% | 0.00% | – |
| Q3 2020 | $772,000 | +107.5% | 106,600 | 0.0% | 0.00% | – |
| Q2 2020 | $372,000 | +83.3% | 106,600 | -22.4% | 0.00% | – |
| Q1 2020 | $203,000 | -11.4% | 137,400 | +17.6% | 0.00% | – |
| Q4 2019 | $229,000 | -61.7% | 116,800 | 0.0% | 0.00% | – |
| Q3 2019 | $598,000 | -24.1% | 116,800 | +6.2% | 0.00% | – |
| Q2 2019 | $788,000 | -1.7% | 110,000 | +82.1% | 0.00% | -100.0% |
| Q1 2019 | $802,000 | +50.5% | 60,400 | -10.8% | 0.00% | – |
| Q4 2018 | $533,000 | -28.9% | 67,700 | 0.0% | 0.00% | – |
| Q3 2018 | $750,000 | -17.5% | 67,700 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $909,000 | +157.5% | 67,700 | -66.9% | 0.00% | – |
| Q4 2016 | $353,000 | -13.7% | 204,256 | -3.1% | 0.00% | – |
| Q3 2016 | $409,000 | 0.0% | 210,731 | -10.3% | 0.00% | – |
| Q2 2016 | $409,000 | +29.0% | 234,974 | 0.0% | 0.00% | – |
| Q1 2016 | $317,000 | -20.2% | 234,974 | 0.0% | 0.00% | – |
| Q4 2015 | $397,000 | -12.9% | 234,974 | 0.0% | 0.00% | – |
| Q3 2015 | $456,000 | -27.8% | 234,974 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $632,000 | -61.1% | 234,974 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $1,626,000 | -29.6% | 234,974 | 0.0% | 0.00% | -50.0% |
| Q4 2014 | $2,310,000 | +43.7% | 234,974 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $1,607,000 | – | 234,974 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $5,746,000 | 15.17% |
| Lynx1 Capital Management LP | 2,325,833 | $8,140,000 | 7.34% |
| TCG Crossover Management, LLC | 5,905,400 | $20,669,000 | 6.20% |
| Versant Venture Management, LLC | 543,753 | $1,903,000 | 3.24% |
| COMMODORE CAPITAL LP | 5,738,500 | $20,085,000 | 3.23% |
| Altium Capital Management LP | 1,750,000 | $6,125,000 | 2.25% |
| Foresite Capital Management IV, LLC | 1,787,094 | $6,255,000 | 2.01% |
| DAFNA Capital Management LLC | 1,703,235 | $5,961,000 | 1.60% |
| Affinity Asset Advisors, LLC | 1,290,511 | $4,517,000 | 1.26% |
| HighVista Strategies LLC | 395,332 | $1,384,000 | 0.79% |